Bone mass in HIV-infected patients: Focus on the role of therapy and sex [1]

Journal of Acquired Immune Deficiency Syndromes

Volumn 33, Issue 3, 2003, Pages 405-407

  Vescini, Fabio ^a   Borderi, Marco ^a   Buffa, Angela ^a   Sinicropi, Giuseppe ^a   Tampellini, Livia ^a   Chiodo, Francesco ^a   Caudarella, Renata ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ABSORPTIOMETRY; ADULT; ANTHROPOMETRIC PARAMETERS; BONE DENSITY; BONE FRAGILITY; BONE MASS; BONE METABOLISM; BONE MINERAL; CALCULATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DENSITOMETRY; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG MECHANISM; EVALUATION; FEMALE; FRACTURE; GENDER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HYPERLIPIDEMIA; INSULIN RESISTANCE; LACTIC ACIDOSIS; LETTER; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; MENSTRUAL CYCLE; OSTEOPENIA; OSTEOPOROSIS; PARAMETRIC TEST; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL ANALYSIS; SURVIVAL RATE; WORLD HEALTH ORGANIZATION; X RAY;

EID: 0038502275     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200307010-00016     Document Type: Letter

References (17)

1. Paton NIJ, Macallan DC, Griffin GE et al. Bone mineral density in patients with human immunodeficiency virus infection. Calcif Tissue Int. 1997;61:30-32.
2. Huang JS, Rietschel P, Hadigan CM, et al. Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy. AIDS. 2001;15(8):975-982.
3. Serrano S, Marinoso ML, Soriano JC, et al. Bone remodelling in human immunodeficiency virus-1-infection patients. A histomorphometric study. Bone. 1995;16(2):185-191.
4. Mellert W, Kleinschmidt A, Schmidt J, et al. Infection of human fibroblasts and osteoblast-like cells with HIV-1. AIDS. 1990;4(6):527-535.
5. Quero JH, Centeno NO, Munoz-Torres M, et al. Alterations in bone turnover in HIV-positive patients. Infection. 1993;21(4):220-222.
6. Tebas P, Powderly WG, Claxton S, et al. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS. 2000;14(4):F63-F67.
7. Cunney RJ, Calligan D, Skehan S, et al. Reduced bone mineral density in HIV-positive men: association with protease-inhibitor therapy and low serum testosterone [abstract 331]. 37th Annual Meeting of the Infectious Disease Society of America; Philadelphia, November 18-21, 1999.
8. Hoy J, Hudson J, Law M et al. Osteopenia in a randomized, multicentre study of protease inhibitor substitution in patients with the lipodystrophy syndrome - extended follow-up to 48 weeks. Antivir Ther. 2000;5(5):42.
9. Nolan D, Upton R, James I, et al. Longitudinal analysis of bone mineral density (BMD) in HIV-infected patients treated with HAART: changes in BMD correlate with change in subcutaneous fat; with an additional independent effect of indinavir therapy to increase BMD. Antivir Ther. 2000;5(5):20.
10. Moyle GJ, Newey C, Baldwin C, et al. Osteopenia: a consequence of HIV not HAART? Antivir Ther. 2000;5(5):43.
11. Carr A, Miller J, Eisman JA et al. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS. 2001;15:703-709.
12. Consensus Development Conference: Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94(6):646-650.
13. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporosis Int. 1994;4(6):368-381.
14. Eastell R. Pathogenesis of postmenopausal osteoporosis. In: Favus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Philadelphia: Lippincott Williams & Wilkins; 1999:260-262.
15. CDC. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR Morb Mortal Wkly Rep. 1992;18:41(RR-17).
16. Looker AC, Orwoll ES, Johnston CC Jr, et al. Prevalence of Low Femoral Bone Density in Older U.S. Adults from NHANES III. J Bone Miner Res. 1997;12(11):1761-1768.
17. Luckey MM. Evaluation of postmenopausal osteoporosis. In: Favus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Philadelphia: Lippincott Williams & Wilkins; 1999:273-277.